Novartis (NVS) total debt

Total debt · fiscal 2025
$35.38B

Novartis (NVS) carried total debt of $35.38B at the end of fiscal 2025 (December 31, 2025). That is 13.2% higher than the $31.26B of fiscal 2024. Figures as of 18 Nov 2026, 07:01 UTC, from Yahoo Finance.

Key facts

Total debt, fiscal 2025
$35.38B
Change on fiscal 2024
+13.2%
Highest on record
$35.38Bfiscal 2025
Lowest on record
$26.35Bfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Novartis total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $35.38B in fiscal 2025 and the lowest $26.35B in fiscal 2023.

Total debt was 0.8× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Novartis total debt, year by year

Novartis (NVS) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$35.38B 13.2% up0.8×
2024$31.26B 18.6% up0.7×
2023$26.35B 5.6% down0.6×
2022$27.91B—0.5×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Novartis and comparable companies
CompanyTotal debtFiscal year
AbbVie ABBV$67.50B2025
Merck & Co MRK$49.34B2025
UnitedHealth Group UNH$78.39B2025
Novartis NVS$35.38B2025
AstraZeneca AZN$29.15B2025
Thermo Fisher Scientific TMO$39.39B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NVS

Novartis, figure by figure

Novartis (NVS) overview: price, valuation and scorecardAll health care companies by market value

Novartis total debt: questions and answers

How much debt does Novartis have?

Novartis (NVS) carried total debt of $35.38B at the end of fiscal 2025 (December 31, 2025). That is 13.2% higher than the $31.26B of fiscal 2024.

What are the highest and lowest total debt figures on record for Novartis?

Across the 4 fiscal years on record (2022–2025), the highest was $35.38B in fiscal 2025 and the lowest $26.35B in fiscal 2023.

How does Novartis's debt compare with its equity?

Total debt was 0.8× shareholders' equity at the end of fiscal 2025.

How is Novartis's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novartis (NVS) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/NVS/total-debt

Underlying data: Yahoo Finance.